Evaluation of Amphastar Pharmaceuticals stock downgraded after the last trading session.
(Updated on Nov 29, 2021)
Sell candidate since 2021-11-29 PDF
The Amphastar Pharmaceuticals stock price fell by -2.16% on the last day (Monday, 29th Nov 2021) from $19.91 to $19.48. and has now fallen 4 days in a row. During the day the stock fluctuated 8.43% from a day low at $19.21 to a day high of $20.83. The price has fallen in 6 of the last 10 days and is down by -8.54% for this period. Volume has increased on the last day by 131 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 251 thousand shares were bought and sold for approximately $4.90 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 10.98% during the next 3 months and, with a 90% probability hold a price between $20.92 and $24.02 at the end of this 3-month period.
Signals & Forecast
There are few to no technical positive signals at the moment. The Amphastar Pharmaceuticals stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. On corrections up, there will be some resistance from the lines at $20.45 and $19.82. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, November 12, 2021, and so far it has fallen -8.54%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Support, Risk & Stop-loss
Amphastar Pharmaceuticals finds support from accumulated volume at $18.68 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.62 between high and low, or 8.43%. For the last week, the stock has had a daily average volatility of 4.71%.
Our recommended stop-loss: We hold an negative evaluation for this stock. No stop-loss is set.
Is Amphastar Pharmaceuticals stock A Buy?
The Amphastar Pharmaceuticals stock holds several negative signals and despite the positive trend, we believe Amphastar Pharmaceuticals will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Current score: -4.929
Predicted Opening Price for Amphastar Pharmaceuticals of Tuesday, November 30, 2021
The predicted opening price is based on yesterday's movements between high, low, and the closing price.
|Fair opening price November 30, 2021||Current price|
Remember To Visit Our YouTube Channel
On Jul 20, 2021 "Northland Securities" gave "$23.00" rating for AMPH. The price target was set to $20.43+2.0%.
AMPH Insider Trading
|Nov 22, 2021||Sell||5 000||Prins Richard K||Stock Option (right to buy)|
|Nov 22, 2021||Sell||5 000||Prins Richard K||Common Stock|
|Nov 22, 2021||Buy||5 000||Prins Richard K||Common Stock|
|Nov 11, 2021||Sell||10 000||Peters William J||Employee Stock Option (right to buy)|
|Nov 11, 2021||Sell||10 000||Peters William J||Common Stock|
Fibonacci Support & Resistance Levels
Accumulated Volume Support & Resistance Levels
Click to get the best stock tips daily for free!
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 100 000+ Happy SubscribersDon't miss out on the runners!
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.